Wetsontwerp tot wijziging van wettelijke bepalingen voor wat de transparantie van de overeenkomsten inzake terugbetaalbare specialiteiten betreft.

This proposal aims to increase transparency regarding agreements on refundable pharmaceutical specialities. It seeks to ensure that the public and relevant stakeholders have better insight into the terms and conditions of these agreements. This measure will affect pharmaceutical companies, healthcare providers, and patients by potentially influencing the availability and cost of certain medicines. It promotes greater accountability in the healthcare sector.